Gritstone Oncology Inc. (NASDAQ: GRTS) stock closed at 12.79 per share at the end of the most recent trading day (a 10.45% change compared to the prior day closing price) with a volume of 1.29M shares and market capitalization of 632.44M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 177 people. Gritstone Oncology Inc. CEO is Andrew R. Allen.

The one-year performance of Gritstone Oncology Inc. stock is 303.14%, while year-to-date (YTD) performance is 224.62%. GRTS stock has a five-year performance of %. Its 52-week range is between 2.54 and 35.2, which gives GRTS stock a 52-week price range ratio of 31.38%

Gritstone Oncology Inc. currently has a PE ratio of -7.60, a price-to-book (PB) ratio of 3.37, a price-to-sale (PS) ratio of 13.23, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -37.27%, a ROC of -43.57% and a ROE of -50.24%. The company’s profit margin is -93.01%, its EBITDA margin is -142.80%, and its revenue ttm is $44.82 Million , which makes it $0.91 revenue per share.

Of the last four earnings reports from Gritstone Oncology Inc., there were 2 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.44 for the next earnings report. Gritstone Oncology Inc.’s next earnings report date is 04th Nov 2021.

The consensus rating of Wall Street analysts for Gritstone Oncology Inc. is Strong Buy (1.25), with a target price of $24, which is +87.65% compared to the current price. The earnings rating for Gritstone Oncology Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Gritstone Oncology Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Gritstone Oncology Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 25.13, ATR14 : 0.86, CCI20 : 108.25, Chaikin Money Flow : 0.11, MACD : 1.12, Money Flow Index : 67.94, ROC : 43.06, RSI : 73.15, STOCH (14,3) : 96.10, STOCH RSI : 0.64, UO : 56.49, Williams %R : -3.90), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Gritstone Oncology Inc. in the last 12-months were: Erin Jones (Option Excercise at a value of $690), Erin Jones (Sold 2 000 shares of value $22 748 ), Raphael Rousseau (Option Excercise at a value of $25 001), Raphael Rousseau (Sold 32 900 shares of value $627 381 ), Roman Yelensky (Option Excercise at a value of $38 500), Roman Yelensky (Sold 10 000 shares of value $221 029 )